1ZLB.F ZAI LAB LTD0000006

Healthcare Biotechnology Frankfurt Exchange
2.30 EUR
Close of Nov 11, 2026
1.26 2.42
Market cap
EUR 2.85B
P/E
-
P/B
5.87x
ROE
-35.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 1ZLB.F undervalued?

Graham number

The Graham number of ZAI LAB LTD0000006 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

ZAI LAB LTD0000006 fundamental analysis

No fundamental analysis for ZAI LAB LTD0000006 yet.

ZAI LAB LTD0000006 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About ZAI LAB LTD0000006

Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include Zejula, an orally administered poly (ADP-ribose) polymerase 1/2 inhibitor for treating ovarian cancer; VYVGART, a human IgG1 antibody fragment for generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropa…

Full company profile